01 / Vendor Profile
NANOCOMPOSIX, INC. Federal Contracts and Awards
UEI EVQMBF7KC8P3 · CAGE 3ZAN8
Federal contract activity attributed to this vendor identity across FY 2019–FY 2025. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2019–FY 2025.
Across FY 2019–FY 2025, FPDS records attribute $3.52M in net contract obligations to NANOCOMPOSIX, INC. across 34 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
NANOCOMPOSIX, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations-$960
FY 2025ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2019 | $2.50M | 7 | 2 | — |
| FY 2020 | $411.5K | 4 | 2 | −83.5% |
| FY 2021 | $250.0K | 5 | 3 | −39.3% |
| FY 2022 | $350.1K | 11 | 3 | +40.0% |
| FY 2023 | $30.1K | 4 | 1 | −91.4% |
| FY 2024 | -$25.0K | 2 | 2 | −183.3% |
| FY 2025 | -$960 | 1 | 1 | +96.2% |
04 / Federal Customers
Which federal agencies buy from NANOCOMPOSIX, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $2.73M | 22 | 77.6% | |
| 7523 | $550.0K | 4 | 15.6% | |
| 2100 | $211.5K | 5 | 6.0% | |
| 7524 | $25.0K | 3 | 0.7% |
05 / Contracting Offices
Which contracting offices buy from NANOCOMPOSIX, INC.?
Ranked by net obligations during FY 2019–FY 2025.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $2.70M | 20 | 76.8% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $550.0K | 4 | 15.6% | |
| W911SR | DEPT OF THE ARMY | $211.5K | 4 | 6.0% | |
| 75N92B | NATIONAL INSTITUTES OF HEALTH | $30.1K | 2 | 0.9% | |
| 75F401 | FOOD AND DRUG ADMINISTRATION | $25.0K | 3 | 0.7% | |
| W81XWH | DEPT OF THE ARMY | $0 | 1 | 0.0% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $1.80M | 9 | 1 | 51.2% |
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $999.0K | 12 | 2 | 28.4% |
| 541713 | RESEARCH AND DEVELOPMENT IN NANOTECHNOLOGY | $686.5K | 10 | 3 | 19.5% |
| 622110 | GENERAL MEDICAL AND SURGICAL HOSPITALS | $30.1K | 2 | 1 | 0.9% |
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $0 | 1 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $2.70M | 19 | 1 | 76.8% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $550.0K | 4 | 1 | 15.6% |
| AD22 | R&D- DEFENSE OTHER: SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT) | $211.5K | 4 | 1 | 6.0% |
| 6505 | DRUGS AND BIOLOGICALS | $30.1K | 2 | 1 | 0.9% |
| B529 | SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA | $25.0K | 3 | 1 | 0.7% |
| AN91 | R&D- MEDICAL: OTHER (BASIC RESEARCH) | $0 | 2 | 2 | 0.0% |
08 / Competition Pattern
How was NANOCOMPOSIX, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for NANOCOMPOSIX, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| 75N93020C00013 | Jul 8, 2025 | -$960 | NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTES OF HEALTH NIAID | 541715 | AN12 |
10 / Interpreting the Profile
How should you evaluate NANOCOMPOSIX, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.